Zentalis Pharmaceuticals (ZNTL) Research & Development (2019 - 2026)
Zentalis Pharmaceuticals (ZNTL) reported Research & Development of $35.16 million for Q2 2026, up 27.4% from $27.61 million a year earlier and up 22.5% from the prior quarter.
Powered by 
Analysis
Zentalis Pharmaceuticals (ZNTL) Research & Development (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Zentalis Pharmaceuticals' Research & Development came in at $116.32 million, down 6.7% year-over-year; for FY2025, it was $107.3 million, down 36.0% from FY2024.
- Research & Development has a five-year compound annual growth rate of 4.8% (FY2020 to FY2025).
- By year, Research & Development came in at $167.77 million in FY2024 (-11.5%), $189.59 million in FY2023 (+9.8%), $172.73 million in FY2022 (-1.6%) and $175.6 million in FY2021 (+106.8%).
- The Q2 2026 figure ranks as the highest quarterly Research & Development since Q3 2024.
- Year over year, Research & Development gained in two of the last eight quarters, with an average decline of 20.1%.
- The high point for year-over-year Research & Development in five years was Q3 2021 (growth of 118.9%); the low point was Q1 2025 (a decline of 45.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $28.72 million (Q1 2026), $29.49 million (Q4 2025) and $22.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Zentalis Pharmaceuticals | 186.34 Mn | 186.34 Mn | - | 35.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.16 Mn |
| Mar 31, 2026 | 28.72 Mn |
| Dec 31, 2025 | 29.49 Mn |
| Sep 30, 2025 | 22.95 Mn |
| Jun 30, 2025 | 27.61 Mn |
| Mar 31, 2025 | 27.25 Mn |
| Dec 31, 2024 | 32.97 Mn |
| Sep 30, 2024 | 36.82 Mn |
| Jun 30, 2024 | 48.39 Mn |
| Mar 31, 2024 | 49.59 Mn |
| Dec 31, 2023 | 51.56 Mn |
| Sep 30, 2023 | 46.77 Mn |
| Jun 30, 2023 | 42.68 Mn |
| Mar 31, 2023 | 48.58 Mn |
| Dec 31, 2022 | 40.62 Mn |
| Sep 30, 2022 | 42.18 Mn |
| Jun 30, 2022 | 43.83 Mn |
| Mar 31, 2022 | 46.11 Mn |
| Dec 31, 2021 | 38.44 Mn |
| Sep 30, 2021 | 54.00 Mn |
API Access
Zentalis Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ZNTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ZNTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ZNTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();